Direct Cell Counting
Directly Count Target Tumor Cells During ADCC, CDC, Viability or Other Assays in the Field of Immuno-Oncology
- Directly image cells within a well
- Perform non-invasive, non-toxic, non-radioactive ADCC based assays
- Acquire direct cell counts per well and export all data as a .CSV file
Direct Cell Counting using Celigo Image Cytometer
Celigo imaging cytometer is a plate-based cytometer that can scan the entire well of standard microplates and captures bright-field and fluorescent images. The captured images are analyzed with the Celigo software to measure size, morphology, cell count, confluence, and fluorescent intensity. The measured parameters are used to generate cell proliferation kinetic data, GFP/RFP expression, tumor spheroid size change, DNA cell cycle analysis, apoptosis, ADCC and CDC cytotoxicity results.
Direct Cell Counting Method using Calcein AM
- Uses Celigo to capture and analyze bright-field and green fluorescent images
- Target suspension and adherent cells are stained with calcein AM and then mixed with the effector cells
- The number of target cells (calcein+) are counted and monitored over time
- Reduction in target cell number indicates cell-mediated or antibody-dependent cell-mediated cytotoxicity
For each well, Celigo image cytometer produces high-resolution whole well images for 96-, 384- and1536-well plates.
Celigo Image Cytometry for Direct Cell Counting in Immuno-Oncology
Imaged tumor cells stained with calcein AM
Counted calcein positive (+) live tumor cells
Directly imaged and counted immune cells include cytolytic cells: CIK cells, NK cells, Neutrophils and CAR-T cells.
Various fluorescent probes and stains were used to identify the target cells and thereby monitor cell killing. They include fluorescent proteins – GFP, RFP, calcein AM, Cell tracer dyes CFSE, CellTraceTM dyes and viability dyes – PI, DAPI.
Stain Target Cells with Calcein AM to Perform Direct Cell Counting using Celigo Image Cytometer
|Detection Method||Description||Existing Issues|
|Radioactivity Release||Measure the release or radiolabels, 51Cr, 101In in the supernatant||Handling hazardous material; Indirect measurement of cell death|
|Fluorescence Release||Measure the release of calcein AM fluorescent molecules in the supernatant||Indirect measurement of cell death; Endpoint assay only|
|LDH Release||Measure the release of cytosolic enzyme in the supernatant||Indirect measurement of cell death; Endpoint assay only|
|Luciferase Reporter Assay||Measure luciferase as the cells die||Indirect measurement of cell death|
|Flow Cytometry||Measure the number of viable cells and viability in the sample||Cannot perform in plates; Must trypsinize for adherent cells|
Cytotoxicity assays play a central role in studying the function of immune effector cells such as cytolytic T lymphocytes (CTL) and natural killer (NK) cells. Traditionally, cytotoxicity assays have been performed using Chromium-51 (51Cr) and calcein release assays.
The assays involve labeling tumor cells (target) with a radioisotope or fluorescent dyes, when the target cells are subjected to CTLs or NK cells (effector) mediated killing, they release the entrapped labels into the media. The amount of released label in the media is measured to determine the level of cytotoxicity the effectors have induced.
A novel cytotoxicity assay using the Celigo imaging cytometer to directly count live, fluorescently labeled target cells has recently been introduced.
Cell images are used by the Celigo software to count live tumor cells for each well over multiple time points.
The same plate was imaged over a 160 minute period to monitor the killing of calcein AM stained tumor target cells by the immune effector cells.
Direct cell counts for each well are reported in the plate map format and counts per well are displayed as a plate map format for easy review.